2025-525085-29-00招募中1 期
A first study in healthy volunteers to examine the safety and tolerability of convalescent plasma given through the nose, as well as the duration of its presence in the nose
Rode Kruis-Vlaanderen2 个研究点 分布在 1 个国家目标入组 104 人开始时间: 2026年7月13日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 104
- 试验地点
- 2
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Elise Wouters
Scientific
Rode Kruis-Vlaanderen
研究点 (2)
Loading locations...
相似试验
已完成
1 期
A study in healthy volunteers to find out how long aticaprant stays in and acts on the body when administered with or without food and with or without fluconazole2023-510472-31-00Janssen Cilag International18
已完成
1 期
A clinical trial in healthy people to look at how the body processes RO7268489 over time and when taken before or after a meal2023-503528-25-00F. Hoffmann-La Roche AG, F. Hoffmann-La Roche AG36
已完成
1 期
Study with healthy volunteers to investigate the safety, tolerability, blood concentration and some effects of various amounts of the pharmaceutical substance SR-8782023-507753-15-00SciRhom GmbH52
招募中
1 期
Study in healthy male participants to compare the blood levels after epoetin alfa (Blau EPO) and Erypo, administered as multiple intravenous injections as well as safety, tolerability and the effects on certain blood values.Treatment of symptomatic anemia associated with chronic renal failure:2025-522246-43-00Blau Farmaceutica S.A.124
已完成
1 期
A study to find out how healthy people tolerate a new drug called S221237.2024-519381-53-00Institut De Recherches Internationales Servier IRIS103